UPDATE 1-Novartis settles civil charges alleging bribery in China - SEC

March 23 (Reuters) - Drugmaker Novartis AG agreed

on Wednesday to pay more than $25 million to the U.S. government

to settle civil charges that it bribed healthcare professionals

in China to boost...

Read more